BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Tirofiban

the treatment of ACUTE CORONARY SYNDROME.

299+ PubMed studies analyzed · 56 RCTs · Evidence Score: 64.4

Research Domains

Tirofiban has been studied across 11 research domains including ❤️ Cardiovascular, 🔬 Oncology, 🫘 Kidney, 🔬 Inflammation, ⏳ Longevity & Aging. The primary research focus is ❤️ Cardiovascular with 63% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tirofiban, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Epoprostenol
2 shared targets
Oseltamivir
2 shared targets
Lamivudine
2 shared targets
Iloprost
2 shared targets
Valsartan
2 shared targets
Lidocaine
2 shared targets
Olmesartan
2 shared targets
Metformin
2 shared targets
Niacin
2 shared targets
Meloxicam
2 shared targets
Loading evidence profile...

This evidence profile for Tirofiban is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.